Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells
- PMID: 16847564
- PMCID: PMC6276004
- DOI: 10.2478/s11658-006-0015-5
Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells
Abstract
Cationic liposome-DNA (lipoplexes) or polymer-DNA (polyplexes) complexes have been used to deliver therapeutic genes, both in vitro and in vivo. However, gene transfer by these non-viral vectors is usually inhibited by biological milieu. A relatively high efficiency of transfection could be achieved in human oral cancer cells transfected with the polycationic liposome, Metafectene, and the polyamine reagent, GeneJammer, in the presence of 60% fetal bovine serum (FBS) (Konopka et al., Cell. Mol. Biol. Lett. 10 (2005) 455-470). Here, we examined the efficacy of these vectors to deliver beta-galactosidase (beta-gal), luciferase and Herpes Simplex Virus thymidine kinase (HSV-tk) genes to SCCVII murine squamous cell carcinoma cells, which are used to generate an orthotopic murine model of oral cancer. We also evaluated the hydrodynamic size and zeta potential of the vectors and the effect of FBS and mouse serum (up to 60%) on the size of Metafectene and GeneJammer complexes with the pCMV.Luc plasmid. Our results indicate that Metafectene and GeneJammer are highly effective in transfecting SCCVII cells. Approximately 60-70% of SCCVII cells transfected with pCMV.lacZ were positive for beta-gal staining. The expression of beta-galactosidase was essentially not affected by serum. Mouse serum (20-60%) reduced both Metafectene-and GeneJammer-mediated luciferase expression by approximately 30-45%, while FBS did not affect transfection efficiency. The delivery of the HSV-tk gene by Metafectene or GeneJammer in the presence of 0% or 60% FBS, followed by GCV treatment for 6 days, resulted in over 90% cytotoxicity. The mean diameters of the DNA complexes of Metafectene and GeneJammer decreased significantly as a function of the serum concentration. The reduction in the size of the lipoplexes and polyplexes by serum was essentially not inhibitory to transfection of SCCVII cells. This is in contrast to previous hypotheses that serum-induced decrease in the size of lipoplexes is the primary cause of serum inhibition of transfection.
Similar articles
-
Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicity.Cell Mol Biol Lett. 2005;10(3):455-70. Cell Mol Biol Lett. 2005. PMID: 16217556
-
Gene therapy for oral cancer: efficient delivery of a 'suicide gene' to murine oral cancer cells in physiological milieu.J Calif Dent Assoc. 2005 Dec;33(12):967-71. J Calif Dent Assoc. 2005. PMID: 16454240
-
Gene delivery to carcinoma cells via novel non-viral vectors: nanoparticle tracking analysis and suicide gene therapy.Eur J Pharm Sci. 2014 Aug 18;60:72-9. doi: 10.1016/j.ejps.2014.03.003. Epub 2014 Apr 19. Eur J Pharm Sci. 2014. PMID: 24751674
-
Transfection of oral cancer cells mediated by transferrin-associated lipoplexes: mechanisms of cell death induced by herpes simplex virus thymidine kinase/ganciclovir therapy.Biochim Biophys Acta. 2006 Nov;1758(11):1703-12. doi: 10.1016/j.bbamem.2006.08.021. Epub 2006 Sep 14. Biochim Biophys Acta. 2006. PMID: 17049485
-
Branched disulfide-based polyamidoamines capable of mediating high gene transfection.Curr Pharm Des. 2010 Jul;16(21):2341-9. doi: 10.2174/138161210791920504. Curr Pharm Des. 2010. PMID: 20618155 Review.
Cited by
-
Synthesis and evaluation of tetramethylguanidinium-polyethylenimine polymers as efficient gene delivery vectors.Biomed Res Int. 2014;2014:459736. doi: 10.1155/2014/459736. Epub 2014 Apr 24. Biomed Res Int. 2014. PMID: 24864245 Free PMC article.
-
Nucleic acid targeting: towards personalized therapy for head and neck cancer.Oncogene. 2016 Jun 23;35(25):3217-26. doi: 10.1038/onc.2015.424. Epub 2015 Nov 23. Oncogene. 2016. PMID: 26592450 Free PMC article. Review.
-
Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.Cell Mol Biol Lett. 2009;14(1):70-89. doi: 10.2478/s11658-008-0034-5. Epub 2008 Oct 6. Cell Mol Biol Lett. 2009. PMID: 18839071 Free PMC article.
-
Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 Vaccines.Biomolecules. 2023 Jul 7;13(7):1088. doi: 10.3390/biom13071088. Biomolecules. 2023. PMID: 37509124 Free PMC article.
-
Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model.Clin Immunol. 2015 Sep;160(1):59-70. doi: 10.1016/j.clim.2015.04.019. Epub 2015 May 8. Clin Immunol. 2015. PMID: 25959685 Free PMC article.
References
-
- Goepfert H. Squamous cell carcinoma of the head and neck: past progress and future promise. CA Cancer J. Clin. 1998;48:195–198. - PubMed
-
- Parkin D.M., Pisani P., Ferlay J. Global cancer statistics. CA Cancer J. Clin. 1999;49:33–64. - PubMed
-
- Harras A., Edwards B.K., Blot W.J., Ries L.A. NIH Publication No. 96-691. Bethesda, MD: National Institutes of Health; 1996. Cancer Rates and Risks.
-
- Hong W.K., Bromer R.H., Amato D.A., Shapsky S., Vincent M., Vaughan C., Willett B., Katz A., Welch J., Fotonoff S., et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer. 1985;56:1242–1245. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources